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With the numbers of persons living with
HIV disease increasing at alarming rates
and the debate over access to antiretrovi-
ral drugs (ARTs) still raging, it is evident
that most patients will try to manage
themselves (self medicate) or will
approach their medical practitioners for
advice. A great number of ‘fad’ products
can be found on the shelves of health food
stores or pharmacies, and it is important
to know what has been clinically tested in
HIV disease and what products should be
avoided. The general practitioner needs
to know what scientific basis exists for the
recommendation for usage of such prod-
ucts.
A study conducted in the Boston area
(USA) found that 68% of 180 HIV-posi-
tive patients interviewed reported the use
of herbs, vitamins or dietary supplements
in conjunction with conventional drugs
specific for HIV. In another report, 39%
of 657 Canadian patients from British
Columbia reported using complementary
and alternative modalities (CAMs) but
this tended to be restricted to young and
highly educated individuals. There is no
doubt then that in developed countries,
patients have recourse to CAM despite
the availability of ARTs. We can therefore
expect that because the price of ARTs has
decreased in South Africa, the demand by
patients will increase. It is also important
to recognise that clinicians may not be
adequately informed on the use of CAM
in HIV disease, since the ‘alternative’
medical approach is not part of the med-
ical curriculum at most medical faculties.
In order to provide some guidelines to
clinicians, this report examines the use of
CAM therapies reported to have immune
modulating activities.These are limited
mainly to the herbal extracts or dietary
supplements known to have such proper-
ties. It does not include however the
potential use of other modalities such as
reflexology, psycho-neuro-immunology
(PNI), aromatherapy, etc., all of which
have been shown to have important bene-
ficial roles in the management of HIV 
disease.
VITAMINS AND OTHER DIETARY
SUPPLEMENTS
It has been demonstrated that micronutri-
ent supplementation may be an important
prophylactic and therapeutic measure for
HIV-1 infected patients and is possibly
one of the few potential interventions for
low-income countries. For instance, poor
maternal micronutrient status has been
shown to be associated with faster clinical
and immunological progression of HIV-1
disease and with adverse birth outcomes,
including fetal retardation and death. In
recent years, many groups have investigat-
ed the outcome of HIV infection in
patients supplemented with vitamin B or
multivitamins, including/excluding vita-
min A in pregnancy. Some studies have
shown that high doses of vitamin B6 sup-
plements were associated with improved
survival of patients while zinc supplemen-
tation was associated with poorer survival.
Since specific micronutrient abnormalities
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serum levels of many of these
(mostly vitamins A, B6, B12 and
zinc) have been associated with
poor outcomes. In dietary uptake
studies, it has been shown that
increased intake of iron, niacin,
riboflavin and vitamins A and E is
associated with decreased progres-
sion to AIDS.1 Finally, in small
preliminary clinical trials, β-
carotene given to infected individu-
als has been shown to increase nat-
ural killer cell markers, white blood
cell numbers, percentage change in
CD4+ counts and CD4:CD8
ratios. It should be remembered
that owing to possible teratogenic
effects of high doses of vitamin A
in pregnancy, the International
Vitamin A Consultative Group has
advised that an upper limit of 
10 000 IU/day should not be
exceeded. There is no doubt that
antioxidants (such as vitamins C
and E) or reduced glutathione or
n-acetyl cysteine are also important
for the management of HIV dis-
ease since most patients are under
oxidative stress and the viral repli-
cation cycle is enhanced due to
increased levels of oxidants.




Many herbs have been used
through the ages in an attempt to
boost the immune response to
infectious agents as well as in can-
cer.The most common of these are
discussed below.
Echinacea
Echinacea purpurea (Fig. 1), E.
angustifolia and E.pallida were the
most popular herbs used by Native
Americans and today we see many
such products on the shelves of
pharmacies or health food stores.
The in vitro testing of extracts of
either the leaves or flowers of such
herbs (especially the polysaccha-
rides) has shown these to increase
the production of tumour necrosis
factor-alpha (TNF-α).The hesita-
tion in using such products in HIV
disease comes from the observation
that most infected patients present
with raised plasma levels of TNF-α
and it is believed that this pro-
inflammatory factor contributes to
the pathogenesis of HIV-related
disease symptoms (weight loss,
chronic pain, etc.). However, it is
argued that the large polysaccha-
rides are poorly absorbed when
orally ingested and that those test-
ed in the test tube were culture-
derived and not the same as those
present in the natural plant extract.
There is some scientific literature
that shows that when cells
obtained from HIV-positive
patients are incubated with
Echinacea extracts, an enhanced
cellular activity can be detected.2
Since these activities are abnormal
in people living with HIV, it can be
argued that the use of such extracts
would translate into clinical bene-
fit. However, a trial to prove or dis-
prove the benefit of this herb in
HIV disease is lacking. We have
seen some preliminary study
results, despite the contraindica-
tion of using it as listed in the
German Commission E mono-
graph on Echinacea. It still remains
controversial and we await further
clinical trials before any final rec-
ommendations can be made.
European mistletoe
Viscum album has been used since
ancient times for a variety of ail-
ments. This parasite seen growing
on oak trees (Fig. 2) was long con-
sidered a sacred symbol and potent
medicine by the Druids. Similarly
to the in vitro activities for
Echinacea, mistletoe extracts have
been shown to enhance the pro-
duction of TNF-α by leucocytes
but unlike Echinacea, administra-
tion of the Viscum album extract to
humans intravenously or orally
leads to raised plasma levels of the
TNF-α. Hence the contraindica-
tion to the use of this herb in HIV
disease. On the other hand, some
studies have provided some justifi-
cation for its use in HIV disease:
aqueous extract of mistletoe
inhibits reverse transcription in
vitro.
Despite the abovementioned reser-
vations with regard to the use of
mistletoe in HIV disease, some
studies have yielded positive
results: a study reported on its sub-
cutaneous application in 12 indi-
viduals and subsequently in a larg-
Many herbs have
been used through
the ages in an
attempt to boost
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Fig. 1. Flower of Ecchinacea purpure a .
Fig. 2. The branches and berries of
the mistletoe (Viscum album).
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er cohort of patients in a dose
escalation study. Patients were
reported to display stable CD4 cell
counts or increases of 20% or
more in the CD4+ lymphocyte lev-
els after 12 weeks of therapy.3
Further studies are necessary to
determine whether Viscum album
extract should be used as an
adjunct to ARTs or other natural
therapies.
Licorice
Two of the most studied botanicals
with immune modulatory activities
are the European Glycyrrhiza
glabra (licorice) and its close Asian
relative Glycyrrhiza uralensis (gan
cao).The main glycoside from
licorice, glycyrrhizin, appears to
have anti-viral and immune-modu-
lating properties. Since 1980, intra-
venous glycyrrhizin has been used
in Japan to treat patients infected
with HIV and it was found to be
effective for suppressing levels of
HIV.4 However, this is not the opti-
mal approach to treating HIV
patients, given its inconvenience
and expense of the intravenous
injection.Three long-term studies
have shown that oral administra-
tion of glycyrrhizin is effective in
suppressing the viral replication
and maintaining immune function
in patients. Although uncon-
trolled, the results seem impressive:
none of the ten patients receiving
the glycyrrhizin deteriorated dur-
ing the study while a group of
patients not on the study showed
progression of the disease.
The dose of glycyrrhizin used was
150 - 225 mg per day in divided
doses — at these doses the
pseudoaldosteronism syndrome
may develop in some patients.
Because glycyrrhizin suppresses
cortisol catabolism by the kidneys
and liver, it may lead to increases
in the serum levels of cortisol and
resultant increased potassium
excretion by the kidneys. If not
checked, hypertension, oedema
and related weight gain or even
more serious problems may devel-
op. These risks may be reduced or
prevented by advising patients to
follow diets high in fruits and veg-
etables or by administering potassi-
um concomitantly.
The results obtained from the use
of licorice are most exciting but
further larger studies are required
in order to confirm the preliminary
observations. In some circles, it is
advocated that since Glycyrrhiza
has many other beneficial con-
stituents, it would be best to use
the whole plant extract rather than
the purified glycyrrhizin.
Furthermore, a deglycyrrhizinated
licorice preparation would be use-
ful for the management of apht-
hous stomatitis (or even peptic
ulcers) but this would not have
much effect on the HIV infection
itself.
Other herbals with immune
modulating properties
Most of the other herbals heralded
for use in HIV infection are very
preliminary in status. The use of
the root and rhizome of the
Siberian gingseng (Eleutherococus
senticosus) has been studied in few
patients and reported to have
caused profound increases in
CD4+ cells after oral ingestion of
the extract.5 However, further stud-
ies have not been forthcoming.
Another botanical used is the
Reishi mushroom extract
(Ganoderma lucidum).This has
been used for centuries in Asia as
an immune modulator for patients
diagnosed with cancer and prelimi-
nary data have shown that the
reishi extract enhances the activi-
ties of the CD4 cells prepared
from HIV-infected patients. Several
compounds with anti-HIV activity
in vitro (especially anti-proteases)
have been identified from the
extract of this mushroom. 6
However, despite these promising
preliminary data, no clinical trial
seems to have been conducted.
The plant sterols/sterolins
A mixture of sterols and sterolins
has been researched in the last 12
years as an alternative management
approach to our local infected pop-
ulation.This mixture was used in
HIV disease after scientific proof
that it had immune modulatory
activities on the TH1 CD4 cells.
Patients on the supplement con-
taining a patented mixture of the
plant sterols/sterolins have shown
stable CD4 cell numbers over a
follow-up period of 40 months,
during which time their viral loads
declined significantly.This is espe-
cially true in the group of patients
who started the study with intact
immune systems (CD4 cell num-
bers above 500/µl blood).These
patients displayed the most
promising effects of this supple-
ment. Interestingly, in this group of
patients, 15% became viral load
undetectable within a period of 12
months after initiation of the
study.7
Furthermore, a cross-sectional
study of patients on the supple-
ment compared with those not on
the supplement but with similar
CD4 cell numbers showed that the
sterol/sterolin supplemented
patients had better cytokine secre-
tion patterns.This study indicated
that those patients on the
sterols/sterolins had a beneficial
TH1 CD4 phenotype: this translates
A mixture of sterols
and sterolins has
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to our local infected
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into better cellular responses to the
virus or virally infected host cells.8
Sterols/sterolins versus Hypoxis plant
(African potato) extract? This is a
decision that many infected
patients face. Our initial study was
conducted on the Hypoxis plant
extract but was discontinued due
to the demonstration of bone mar-
row suppression in several patients
with terminal cancer.The total
plant extract contains molecules
with unknown chemical structures
at present and these may have
long-term detrimental effects.
Furthermore, many case reports
from KwaZulu-Natal have
emerged concerning the admit-
tance to the emergency services of
patients who had ingested concoc-
tions derived from this plant and
yet many such preparations are
freely available from street vendors.
IMMUNE MODULATION:
GOOD OR BAD?
We are aware of several new stud-
ies evaluating the use of other mol-
ecules with immune-modulating
properties in HIV disease. For
instance, new studies are evaluat-
ing the use of recombinant
cytokines, hormone precursors,
antioxidants and even thalidomide.
The impact of these on the
immune response of HIV-infected
individuals seems promising as
adjuvants in the management of
infected patients.
For too long the immune system
has remained the orphan in this
disease and it is time to include
such management strategies since
the use of such therapies could
prevent many of the severe defi -
ciencies and immune dysfunction.
We should never contemplate that
such approaches could ever replace
the use of antiretroviral regimens.
However, modulation of an effec-
tive immunity to the virus itself has
a major role to play in this infec-
tion. After all, it is the loss of effec-
tive immunity that allows disease
progression.
References available on request.
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IN A NUTSHELL
Many HIV-infected patients have
recourse to alternative therapies
freely available on the market.
Although marketed as immunity-
enhancing herbs, not all have
been clinically tested specifically
in HIV disease.
Some therapies should be used
with reservation: those which can
promote inflammation should be
avoided in HIV disease.
Due to the numerous micro-nutri-
ent deficiencies which develop in
HIV patients, balanced multivit a-
min intake should be encour-
aged.
Many complementary therapies
can be used in conjunction with
registered ARVs: the practitioner




Blood pressure and cogni-
tive impairment in hear t
failure patients
In an Italian study published
in Neurology (2001; 57: 1986-
1992), cognitive impairment
was found significantly more
frequently among patients
with heart failure than among
those without heart failure
(26% v. 19%). In analyses
adjusted for several con-
founding variables, cognitive
dysfunction was associated
with lower systolic blood
pressure (BP) among hear t
failure patients: systolic BP
lower than 130 mmHg was
found in 46% of heart failure
patients with cognitive
impairment and in 27% of
those without impairment —
a significant difference.
Among patients without heart
failure, there was no correla-
tion between BP and cogni-
tive dysfunction.
Allan S Brett, MD, writing in
Journal Watch (8 January
2002), comments,
‘Undoubtedly there are other
confounding variables that
were not accounted for in this
study, and causal links
between heart failure, cogni-
tion, and BP remain unclear.
Because hypotensive drugs
are a mainstay of heart failure
therapy, we will face a dilem-
ma if additional research
shows that active lowering of
systolic BP to below 130
mmHg increases risk for cog-
nitive dysfunction among
heart failure patients.’
